首页 | 本学科首页   官方微博 | 高级检索  
检索        

可溶性血管内皮生长因子受体-1与子痫前期相关因素分析
引用本文:何云,王晨虹,钟梅,石泽真,宋彩珍,周璐,苏海燕.可溶性血管内皮生长因子受体-1与子痫前期相关因素分析[J].广东医学,2011,32(15).
作者姓名:何云  王晨虹  钟梅  石泽真  宋彩珍  周璐  苏海燕
作者单位:何云,王晨虹,石泽真,周璐,苏海燕(广东省深圳市妇幼保健院产科,518028);钟梅(南方医科大学南方医院妇产科,广州,510515);宋彩珍(湖北省武汉市武昌医院检验科,430071)
基金项目:广东省深圳市科技计划项目
摘    要:目的 研究可溶性血管内皮生长因子受体- 1 ( sFlt-1) 及临床生化指标在正常妊娠和子痫前期(轻度、重度)组母体外周血中表达差异。方法 选取子痫前期轻度16例、子痫前期重度孕妇24例,18例与之年龄孕周相匹配的血压正常单胎孕妇(对照组) ,用ELISA方法测定其外周血中sFlt-1的水平,检验科常规测量各项生化指标。结果 外周血中sFlt-1水平、血尿酸、血清肌酐、β2微球蛋白在子痫前期重度组明显高于对照组, 分别为(11039.43 ±1305.84) 、(3158.27±2658.13)ng/L ;(379.87 ±82.11) 、(266.41±57.69)μmol/ L;(61.65±12.24) 、(50.87±8.35)μmol/ L;(2.88±0.82)、(1.94±0.49)mg/L;血浆白蛋白水平(29.26±3.92)g/ L低于对照组(35.52±6.92 )g/ L,以上两者差异均有显著性( P < 0.05) 。血清sFlt-1水平在对照组、子痫前期轻度、子痫前期重度中逐渐升高分别为(3158.27±2658.13)、(6060.75±2992.92 )、(11039.9 ±1305.84)ng/L。结论 sFlt-1 在子痫前期组孕妇的外周血中表达升高, 可能与子痫前期的病因及病理生理有关,与疾病的严重程度相关,联合其他指标可以作为预测和判断子痫前期疾病严重性的指标。

关 键 词:可溶性血管内皮生长因子受体-1  子痫前期  酶联免疫吸附测定

Association study of preeclampsia and soluble vascular endothelial growth factor receptor-1
Abstract:Objective   To investigate the association between sFlt - 1 and and pre-eclampsia. Methods   sFlt-1 concentration of Serum was measured by enzy- me linked immunosorbent assay ( ELISA) in 40 preeclampsia patients(16 cases of mild preeclampsia (mPE group);and 24 cases of severe preeclampsia (sPE group)). 18 normal pregnant wo- men .They are all singleton pregnancies matched with age,gestational age respectively. We collected clinical biochemical indicators from case data. Results concentration of sFlt-1,serum uric acid , β2 microglob- ulin and serum creatinine in severe preeclampsia group were higher than those in control group, respectively are (11039.43 ±1305.84) vs(3158.27±2658.13)ng/L;(379.87 ±82.11) vs (266.41±57.69)μmol/ L;(61.65±12.24) vs(50.87±8.35)μmol/ L;(2.88±0.82)vs( 1.94±0.49)mg/L; concentration of Plasma albu- min (29.26 + 3.92) g/L was lower than control group (35.52 + 6.92) g/L. significant differences were found ( P < 0.05) between control group and severe preeclampsia group .Serum sFlt - 1 level in the control group, mild preeclampsia, severe preecla- mpsia gradually rise (3158.27±2658.13)、(6060.75±2992.92 )、(11039.9 ±1305.84)ng/L. Conclusion  High maternal serum sFlt-1 may relate to the pathogen- nesis and pathophy- siology of preeclampsia and relate to the severity of the disord- er. com- binded with other indicators index maybe predict and judge preeclampsia disease severity.
Keywords:
本文献已被 CNKI 万方数据 等数据库收录!
点击此处可从《广东医学》浏览原始摘要信息
点击此处可从《广东医学》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号